The SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER): Study Design and Protocol - 21/11/24

Doi : 10.14283/jpad.2022.5 
X. Xu 1, 2, K.A. Chew 2, Z.X. Wong 3, A.K.S. Phua 3, E.J.Y. Chong 3, C.K.L. Teo 3, N. Sathe 3, Y.C. Chooi 4, W.P.F. Chia 5, C.J. Henry 6, 7, 8, E. Chew 9, 10, M. Wang 11, A.B. Maier 12, 13, 14, N. Kandiah 15, 16, Christopher Li-Hsian Chen, Dr. 2, 3, 17,
1 School of Public Health and the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China 
2 Memory, Ageing and Cognition Centre (MACC), Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore 
3 Memory, Ageing and Cognition Centre (MACC), Department of Psychological Medicine, National University Hospital, Singapore, Singapore 
4 Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore 
5 School of Sports, Health and Leisure, Republic Polytechnic, Singapore, Singapore 
6 Clinical Nutrition Research Centre, Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore 
7 Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore 
8 Singapore Institute of Food and Biotechnology Innovation, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore 
9 i Division of Neurology, Department of Medicine, National University Hospital, Singapore, Singapore 
10 Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore 
11 Division of Sports Medicine & Surgery, Orthopaedic Surgery, National University Hospital, Singapore, Singapore 
12 Department of Human Movement Sciences, @Age Amsterdam, Vrije Universiteit Amsterdam, Amsterdam Movement Sciences, Amsterdam, the Netherlands 
13 Healthy Longevity Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore 
14 Centre for Healthy Longevity, @Age Singapore National University Health System, Singapore, Singapore 
15 Department of Neurology, National Neuroscience Institute, Singapore, Singapore 
16 Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore 
17 Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, MD3, 04-01, 16 Medical Drive, 117600, Singapore, Singapore 

r phccclh@nus.edu.sg phccclh@nus.edu.sg

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

The SINgapore GERiatric intervention study to reduce cognitive decline and physical frailty (SINGER) randomised controlled trial (RCT) uses a multidomain lifestyle interventions approach, shown to be effective by the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) trial, to delay cognitive decline.

Objective

To investigate the efficacy and safety of the SINGER multidomain lifestyle interventions in older adults at risk for dementia to delay cognitive decline.

Participants

1200 participants between 60–77 years old, with Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) dementia risk score ≥6, fulfilling at least one of the following LIBRA index for diet, cognitive activity, physical activity and a Montreal Cognitive Assessment (MoCA) score ≥18, ≤27 points, will be recruited across Singapore.

Methods

SINGER is a 2-year multi-site RCT consisting of multidomain interventions: dietary advice, exercise, cognitive training, and vascular risk factors management. Participants will be randomised into either the Self-Guided Intervention (SGI; general lifestyle and health information and resources) or Structured Lifestyle Intervention (SLI) group. The SLI comprises diet training (6 group and 3 individual sessions over 12 months); exercise (supervised: 1-hour twice weekly for 6 months, unsupervised: 2–3/week for the rest of the study duration); cognitive sessions (15–30 minutes/session, 3/week for 6 months, together with 10 workshops in 24 months). Vascular management takes place every 3–6 months or otherwise as specified by study physicians. The primary outcome is global cognition measured using the modified Neuropsychological Battery assessing performance in various domains, such as episodic memory, executive function and processing speed. Secondary outcome measures include: domain-specific cognition and function, imaging evidence of brain and retinal changes, incidence and progression of chronic diseases, blood biomarkers, quality of life, mental health and cost-benefit analysis.

Conclusions

SINGER is part of the Worldwide-FINGERS international network, which is at the forefront of harmonizing approaches to effective non-pharmacological interventions in delaying cognitive decline in older adults at risk of dementia. By establishing the efficacy of multidomain interventions in preventing cognitive decline, SINGER aims to implement the findings into public health and clinical practices by informing policy makers, and guiding the design of community- and individual-level health promotion initiatives.

Le texte complet de cet article est disponible en PDF.

Key words : Randomized controlled trial, multi-domain life style interventions, cognitive dysfunction, aged


Plan


 Equal contribution


© 2022  THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 9 - N° 1

P. 40-48 - janvier 2022 Retour au numéro
Article précédent Article précédent
  • Multimodal Preventive Trial for Alzheimer’s Disease: MIND-ADmini Pilot Trial Study Design and Progress
  • S. Sindi, C. Thunborg, A. Rosenberg, P. Andersen, S. Andrieu, L.M. Broersen, N. Coley, C. Couderc, C.Z. Duval, G. Faxen-Irving, G. Hagman, M. Hallikainen, K. Håkansson, J. Lehtisalo, N. Levak, F. Mangialasche, J. Pantel, E. Kekkonen, A. Rydström, A. Stigsdotter-Neely, A. Wimo, T. Ngandu, H. Soininen, T. Hartmann, A. Solomon, Miia Kivipelto
| Article suivant Article suivant
  • Evidence-Based Tools for Dietary Assessments in Nutrition Epidemiology Studies for Dementia Prevention
  • K.A. Abbott, J.M. Posma, S. Garcia-Perez, C. Udeh-Momoh, S. Ahmadi-Abhari, L. Middleton, Gary Frost

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.